Received Mar 5, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | OT |
No symptomatic events were reported per nurse.; Inbound call from nurse to report an AE for PROQUAD. Caller reported that an adult male patient had received a dose of PROQUAD for measles prevention due to low titer levels recorded from. Patient noted that there was a measles outbreak and wanted to; This spontaneous report was received from a Nurse and refers to a(n) 62-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 18-Feb-2026, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), formulation: injection, administered by intramuscular route (lot #, expiration date, exact dose and anatomical location were not provided) for prevention (prevention due to low measles titer levels). The vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (lot # and expiration date were not reported). Patient noted that there was a measles outbreak and wanted to be protected from it (product administered to patient of inappropriate age). No symptomatic events were reported per nurse (no adverse event).
sterile diluent
Test Name: Measles titer; Result Unstructured Data: low titer levels